We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cutera Receives FDA Warning Letter for Website Promoting Vaginal Rejuvenation
Cutera Receives FDA Warning Letter for Website Promoting Vaginal Rejuvenation
Brisbane, Calif.-based Cutera, a manufacturer of medical aesthetic and dermatology devices, was hit with an FDA warning letter for a still-functioning website for a vaginal rejuvenation product the company removed from the market in 2019.